United States · FDA National Drug Code directory
ADZYNMA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64764-140_758b0d1f-9d6c-42f9-a23b-6f75e9181842
- Product NDC
- 64764-140
- Form
- KIT
- Composition / generic term
- Apadamtase Alfa
- Labeler
- TAKEDA PHARMACEUTICALS AMERICA, INC.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20231109
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (64764-140-05) * 500 [iU] in 1 VIAL, SINGLE-DOSE (64764-130-01) * 5 mL in 1 VIAL, GLASS (64764-515-50) · 64764-140-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →